Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month ...
TORONTO--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough ...